Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Hoffmann-La Roche
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Histological diagnosis of follicular non-Hodgkin's lymphoma
Complete or partial response to first-line induction therapy with chemotherapy with rituximab
Participants about to receive first-line rituximab maintenance treatment for follicular non-Hodgkin's lymphoma according to the local label
You may not be if
Pregnant or lactating women
Receipt of an investigational drug within 30 days prior to initiation of observational drug
Any medical or psychological alteration that, to criterion of the investigator, can jeopardize the capacity of the participant to grant informed consent
Central nervous system involvement
Hepatitis B or C virus infection or human immunodeficiency virus infection